Wedbush Increases Earnings Estimates for Avalo Therapeutics
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Free Report) – Stock analysts at Wedbush upped their Q1 2025 earnings estimates for shares of Avalo Therapeutics in a research note issued to investors on Thursday, March 20th. Wedbush analyst R. Driscoll now expects that the company will post earnings per share of $0.63 for the quarter, up from […]
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Free Report) – Stock analysts at Wedbush upped their Q1 2025 earnings estimates for shares of Avalo Therapeutics in a research note issued to investors on Thursday, March 20th. Wedbush analyst R. Driscoll now expects that the company will post earnings per share of $0.63 for the quarter, up from […]
